Top

Published in:

01-10-2010 | Editorial and Commentary

The TNM classification of breast cancer: need for change

Authors: Paolo Arnone, Stefano Zurrida, Giuseppe Viale, Silvia Dellapasqua, Emilia Montagna, Paola Arnaboldi, Mattia Intra, Umberto Veronesi

Published in: Updates in Surgery | Issue 2/2010

Excerpt

The need for a unified and internationally accepted cancer staging system was recognized in the first half of the twentieth century and led to the publication of the first International Union Against Cancer (UICC) [1] staging system in the 1950s. This was followed by the International Federation of Gynecology and Obstetrics (FIGO) classification of women’s cancers [2] and the American Joint Committee for Cancer (AJCC) classification, the first edition of which was published in 1977 [3]. …

Denoix PF, Schwartz D (1959) General rules for classification of cancers and presentation of the therapeutic results. Mem Acad Chir (Paris) 85(15–16):415–424

Odicino F, Pecorelli S, Zigliani L, Creasman WT (2008) History of the FIGO cancer staging system. Int J Gynaecol Obstet 101(2):205–210CrossRefPubMed

Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (eds) (2002) AJCC cancer staging manual, 6th ed. Springer, New York, NY

Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249(6):751–757CrossRefPubMed

Leydon GM, Boulton M, Moynihan C, Alison J, Mossman J, Markella B, McPherson K (2000) Cancer Patients’ information needs and information seeking behaviour: in depth interview study. Brit Med J 320(7239):909–913CrossRefPubMed

Costelloe M, Nelson L (2004) The needs of recently diagnosed cancer patients. Nurs Stand 19(13):42–44PubMed

Veronesi U, Viale G, Rotmensz Goldhirsch A (2006) Rethinking TNM: breast cancer TNM classification for treatment decision-making and research. Breast 15(1):3–8CrossRefPubMed

Veronesi U, Zurrida S, Viale G, Galimberti V, Arnone P, Nolè F (2009) Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research. Breast J 3:291–295CrossRef

Veronesi U, Zurrida S, Goldhirsch A, Rotmensz N, Viale G (2009) Breast cancer classification: time for a change. J Clin Oncol 27(15):2427–2428CrossRefPubMed

10.

Tavassoli FA (1998) Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 11:140–154PubMed

11.

Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553CrossRefPubMed

12.

Veronesi U, Zurrida S, Mazzarol G, Viale G (2001) Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection. World J Surg 25(6):806–808CrossRefPubMed

13.

Galimberti V (2006) International breast cancer study group trial of sentinel node biopsy. J Clin Oncol 24(1):210–211CrossRefPubMed

14.

Fernando HC (2008) Radiofrequency ablation to treat non-small cell lung cancer and pulmonary metastases. Ann Thorac Surg 85:S780–S784CrossRefPubMed

15.

Ranjan T, Abrey LE (2009) Current management of metastatic brain disease. Neurotherapeutics 6(3):598–603CrossRefPubMed

16.

Kennedy JE (2005) High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 5(4):321–327CrossRefPubMed

17.

Chiappa A, Makuuchi M, Lygidakis NJ, Zbar AP, Chong G, Bertani E, Sitzler PJ, Biffi R, Pace U, Bianchi PP, Contino G, Misitano P, Orsi F, Travaini L, Trifirò G, Zampino MG, Fazio N, Goldhirsch A, Andreoni B (2009) The management of colorectal liver metastases: expanding the role of hepatic resection in the age of multimodal therapy. Crit Rev Oncol Hematol 72(1):65–75CrossRefPubMed

18.

Paganelli G, Chinol M (2003) Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods? Eur J Nucl Med Mol Imaging 30(5):773–776CrossRefPubMed

19.

Silvestrini R, Daidone MG, Mastore M, Di Fronzo G, Coradini D, Boracchi P, Squicciarini P, Salvadori B, Veronesi U (1993) Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy. J Clin Oncol 6:1150–1155

20.

Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ (2007) Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer. Ann Oncol 18(7):1133–1144 10th St. Gallen conferenceCrossRefPubMed

21.

Curigliano G, Viale G, Bagnardi PV, Fumagalli L, Locatelli M, Rotmensz N, Ghisini R, Zurrida S, Veronesi P, Goldhirsch A (2009) Clinical Relevance of HER2 Overexpression/amplification in patients with small tumor size and node-negative breast cancer. J Clin Oncol 27:5693–5699CrossRefPubMed

22.

Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ (1999) Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol 17:1983–1987PubMed

23.

Persons DL, Tubbs RR, Cooley LD, Dewald GW, Dowling PK, Du E, Mascarello JT, Rao KW, Wilson KS, Wolff DJ, Habegger-Vance G (2006) HER-2 fluorescence in situ hybridization: Results from the survey program of the College of American Pathologists. Arch Pathol Lab Med 130:325–331PubMed

24.

Dal Lago L, Durbecq V, Desmedt C, Salgado R, Verjat T, Lespagnard L, Ma Y, Veys I, Di Leo A, Sotiriou C, Piccart M, Larsimont D (2006) Correction for chromosome 17 is critical for determination of true Her-2/neu gene amplification status in breast cancer. Mol Cancer Ther 5:2572–2579CrossRefPubMed

25.

Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge OR, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406:747–752CrossRefPubMed

26.

Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lønning P, Børresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874CrossRefPubMed

Title: The TNM classification of breast cancer: need for change
Authors: Paolo Arnone
Stefano Zurrida
Giuseppe Viale
Silvia Dellapasqua
Emilia Montagna
Paola Arnaboldi
Mattia Intra
Umberto Veronesi
Publication date: 01-10-2010
Publisher: Springer Milan
Published in: Updates in Surgery / Issue 2/2010
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI: https://doi.org/10.1007/s13304-010-0014-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The TNM classification of breast cancer: need for change

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2010

Erratum to: How does dexamethasone influence surgical outcome after laparoscopic Nissen fundoplication? A randomized double-blind placebo-controlled trial

Pancreaticoduodenectomy with unusual artery reconstruction in a patient with celiac axis occlusion: report of a case

Experience on surgical treatment of gastrointestinal stromal tumor of the stomach

Necrotizing fasciitis: a surgical emergency

Vascular resections in pancreatic cancer

Single-incision laparoscopic right colectomy for cancer: a single-centre preliminary experience